Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Jesper L. V. Maag is active.

Publication


Featured researches published by Jesper L. V. Maag.


Nucleic Acids Research | 2015

lncRNAdb v2.0: expanding the reference database for functional long noncoding RNAs

Xiu Cheng Quek; Daniel W. Thomson; Jesper L. V. Maag; Nenad Bartonicek; Bethany Signal; Michael B. Clark; Brian S. Gloss; Marcel E. Dinger

Despite the prevalence of long noncoding RNA (lncRNA) genes in eukaryotic genomes, only a small proportion have been examined for biological function. lncRNAdb, available at http://lncrnadb.org, provides users with a comprehensive, manually curated reference database of 287 eukaryotic lncRNAs that have been described independently in the scientific literature. In addition to capturing a great proportion of the recent literature describing functions for individual lncRNAs, lncRNAdb now offers an improved user interface enabling greater accessibility to sequence information, expression data and the literature. The new features in lncRNAdb include the integration of Illumina Body Atlas expression profiles, nucleotide sequence information, a BLAST search tool and easy export of content via direct download or a REST API. lncRNAdb is now endorsed by RNAcentral and is in compliance with the International Nucleotide Sequence Database Collaboration.


Molecular Cancer | 2016

Long noncoding RNAs in cancer: mechanisms of action and technological advancements

Nenad Bartonicek; Jesper L. V. Maag; Marcel E. Dinger

The previous decade has seen long non-coding RNAs (lncRNAs) rise from obscurity to being defined as a category of genetic elements, leaving its mark on the field of cancer biology. With the current number of curated lncRNAs increasing by 10,000 in the last five years, the field is moving from annotation of lncRNA expression in various tumours to understanding their importance in the key cancer signalling networks and characteristic behaviours. Here, we summarize the previously identified as well as recently discovered mechanisms of lncRNA function and their roles in the hallmarks of cancer. Furthermore, we identify novel technologies for investigation of lncRNA properties and their function in carcinogenesis, which will be important for their translation to the clinic as novel biomarkers and therapeutic targets.


Frontiers in Neuroscience | 2015

Dynamic expression of long noncoding RNAs and repeat elements in synaptic plasticity.

Jesper L. V. Maag; Debabrata Panja; Ida Sporild; Sudarshan Patil; Dominik C. Kaczorowski; Clive R. Bramham; Marcel E. Dinger; Karin Wibrand

Long-term potentiation (LTP) of synaptic transmission is recognized as a cellular mechanism for learning and memory storage. Although de novo gene transcription is known to be required in the formation of stable LTP, the molecular mechanisms underlying synaptic plasticity remain elusive. Noncoding RNAs have emerged as major regulatory molecules that are abundantly and specifically expressed in the mammalian brain. By combining RNA-seq analysis with LTP induction in the dentate gyrus of live rats, we provide the first global transcriptomic analysis of synaptic plasticity in the adult brain. Expression profiles of mRNAs and long noncoding RNAs (lncRNAs) were obtained at 30 min, 2 and 5 h after high-frequency stimulation of the perforant pathway. The temporal analysis revealed dynamic expression profiles of lncRNAs with many positively, and highly, correlated to protein-coding genes with known roles in synaptic plasticity, suggesting their possible involvement in LTP. In light of observations suggesting a role for retrotransposons in brain function, we examined the expression of various classes of repeat elements. Our analysis identifies dynamic regulation of LINE1 and SINE retrotransposons, and extensive regulation of tRNA. These experiments reveal a hitherto unknown complexity of gene expression in long-term synaptic plasticity involving the dynamic regulation of lncRNAs and repeat elements. These findings provide a broader foundation for elucidating the transcriptional and epigenetic regulation of synaptic plasticity in both the healthy brain and in neurodegenerative and neuropsychiatric disorders.


Scientific Reports | 2017

Benchmarking of RNA-sequencing analysis workflows using whole-transcriptome RT-qPCR expression data

Celine Everaert; Manuel Luypaert; Jesper L. V. Maag; Quek Xiu Cheng; Marcel E. Dinger; Jan Hellemans; Pieter Mestdagh

RNA-sequencing has become the gold standard for whole-transcriptome gene expression quantification. Multiple algorithms have been developed to derive gene counts from sequencing reads. While a number of benchmarking studies have been conducted, the question remains how individual methods perform at accurately quantifying gene expression levels from RNA-sequencing reads. We performed an independent benchmarking study using RNA-sequencing data from the well established MAQCA and MAQCB reference samples. RNA-sequencing reads were processed using five workflows (Tophat-HTSeq, Tophat-Cufflinks, STAR-HTSeq, Kallisto and Salmon) and resulting gene expression measurements were compared to expression data generated by wet-lab validated qPCR assays for all protein coding genes. All methods showed high gene expression correlations with qPCR data. When comparing gene expression fold changes between MAQCA and MAQCB samples, about 85% of the genes showed consistent results between RNA-sequencing and qPCR data. Of note, each method revealed a small but specific gene set with inconsistent expression measurements. A significant proportion of these method-specific inconsistent genes were reproducibly identified in independent datasets. These genes were typically smaller, had fewer exons, and were lower expressed compared to genes with consistent expression measurements. We propose that careful validation is warranted when evaluating RNA-seq based expression profiles for this specific gene set.


Scientific Reports | 2017

The long non-coding RNA NEAT1 is responsive to neuronal activity and is associated with hyperexcitability states.

Guy Barry; James Briggs; Do Won Hwang; Sam P. Nayler; Patrick R.J. Fortuna; Nicky Jonkhout; Fabien Dachet; Jesper L. V. Maag; Pieter Mestdagh; Erin M. Singh; Lotta Avesson; Dominik C. Kaczorowski; Ezgi Ozturk; Nigel C. Jones; Irina Vetter; Luis Arriola-Martinez; Jianfei Hu; Glória Regina Franco; Victoria M. Warn; Andrew Gong; Marcel E. Dinger; Frank Rigo; Leonard Lipovich; Margaret J. Morris; Terence J. O'Brien; Dong Soo Lee; Jeffrey A. Loeb; Seth Blackshaw; John S. Mattick; Ernst J. Wolvetang

Despite their abundance, the molecular functions of long non-coding RNAs in mammalian nervous systems remain poorly understood. Here we show that the long non-coding RNA, NEAT1, directly modulates neuronal excitability and is associated with pathological seizure states. Specifically, NEAT1 is dynamically regulated by neuronal activity in vitro and in vivo, binds epilepsy-associated potassium channel-interacting proteins including KCNAB2 and KCNIP1, and induces a neuronal hyper-potentiation phenotype in iPSC-derived human cortical neurons following antisense oligonucleotide knockdown. Next generation sequencing reveals a strong association of NEAT1 with increased ion channel gene expression upon activation of iPSC-derived neurons following NEAT1 knockdown. Furthermore, we show that while NEAT1 is acutely down-regulated in response to neuronal activity, repeated stimulation results in NEAT1 becoming chronically unresponsive in independent in vivo rat model systems relevant to temporal lobe epilepsy. We extended previous studies showing increased NEAT1 expression in resected cortical tissue from high spiking regions of patients suffering from intractable seizures. Our results indicate a role for NEAT1 in modulating human neuronal activity and suggest a novel mechanistic link between an activity-dependent long non-coding RNA and epilepsy.


BMC Genomics | 2017

Widespread promoter methylation of synaptic plasticity genes in long-term potentiation in the adult brain in vivo.

Jesper L. V. Maag; Dominik C. Kaczorowski; Debabrata Panja; Timothy J. Peters; Clive R. Bramham; Karin Wibrand; Marcel E. Dinger

BackgroundDNA methylation is a key modulator of gene expression in mammalian development and cellular differentiation, including neurons. To date, the role of DNA modifications in long-term potentiation (LTP) has not been explored.ResultsTo investigate the occurrence of DNA methylation changes in LTP, we undertook the first detailed study to describe the methylation status of all known LTP-associated genes during LTP induction in the dentate gyrus of live rats. Using a methylated DNA immunoprecipitation (MeDIP)-array, together with previously published matched RNA-seq and public histone modification data, we discover widespread changes in methylation status of LTP-genes. We further show that the expression of many LTP-genes is correlated with their methylation status. We show that these correlated genes are enriched for RNA-processing, active histone marks, and specific transcription factors. These data reveal that the synaptic activity-evoked methylation changes correlates with pre-existing activation of the chromatin landscape. Finally, we show that methylation of Brain-derived neurotrophic factor (Bdnf) CpG-islands correlates with isoform switching from transcripts containing exon IV to exon I.ConclusionsTogether, these data provide the first evidence of widespread regulation of methylation status in LTP-associated genes.


Molecular Cancer Research | 2017

Novel Aberrations Uncovered in Barrett's Esophagus and Esophageal Adenocarcinoma Using Whole Transcriptome Sequencing

Jesper L. V. Maag; Oliver M. Fisher; Angelique Levert-Mignon; Dominik C. Kaczorowski; Melissa Thomas; Damian J. Hussey; David I. Watson; Antony Wettstein; Yuri V. Bobryshev; Melanie Edwards; Marcel E. Dinger; Reginald V. Lord

Esophageal adenocarcinoma (EAC) has one of the fastest increases in incidence of any cancer, along with poor five-year survival rates. Barretts esophagus (BE) is the main risk factor for EAC; however, the mechanisms driving EAC development remain poorly understood. Here, transcriptomic profiling was performed using RNA-sequencing (RNA-seq) on premalignant and malignant Barretts tissues to better understand this disease. Machine-learning and network analysis methods were applied to discover novel driver genes for EAC development. Identified gene expression signatures for the distinction of EAC from BE were validated in separate datasets. An extensive analysis of the noncoding RNA (ncRNA) landscape was performed to determine the involvement of novel transcriptomic elements in Barretts disease and EAC. Finally, transcriptomic mutational investigation of genes that are recurrently mutated in EAC was performed. Through these approaches, novel driver genes were discovered for EAC, which involved key cell cycle and DNA repair genes, such as BRCA1 and PRKDC. A novel 4-gene signature (CTSL, COL17A1, KLF4, and E2F3) was identified, externally validated, and shown to provide excellent distinction of EAC from BE. Furthermore, expression changes were observed in 685 long noncoding RNAs (lncRNA) and a systematic dysregulation of repeat elements across different stages of Barretts disease, with wide-ranging downregulation of Alu elements in EAC. Mutational investigation revealed distinct pathways activated between EAC tissues with or without TP53 mutations compared with Barretts disease. In summary, transcriptome sequencing revealed altered expression of numerous novel elements, processes, and networks in EAC and premalignant BE. Implications: This study identified opportunities to improve early detection and treatment of patients with BE and esophageal adenocarcinoma. Mol Cancer Res; 15(11); 1558–69. ©2017 AACR.


Frontiers in Neuroscience | 2016

Corrigendum: Dynamic expression of long noncoding RNAs and repeat elements in synaptic plasticity

Jesper L. V. Maag; Debabrata Panja; Ida Sporild; Sudarshan Patil; Dominik C. Kaczorowski; Clive R. Bramham; Marcel E. Dinger; Karin Wibrand

[This corrects the article on p. 351 in vol. 9, PMID: 26483626.].


Genome Biology | 2017

Intergenic disease-associated regions are abundant in novel transcripts.

Nenad Bartonicek; Michael B. Clark; Xiu Cheng Quek; J. R. Torpy; Antonia L. Pritchard; Jesper L. V. Maag; Brian S. Gloss; Joanna Crawford; Ryan J. Taft; Nicholas K. Hayward; Grant W. Montgomery; John S. Mattick; Timothy R. Mercer; Marcel E. Dinger


Annals of Surgical Oncology | 2016

CD151 Gene and Protein Expression Provides Independent Prognostic Information for Patients with Adenocarcinoma of the Esophagus and Gastroesophageal Junction Treated by Esophagectomy

Oliver M. Fisher; Angelique Levert-Mignon; Christopher W. Lehane; Natalia K. Botelho; Jesper L. V. Maag; Melissa Thomas; Melanie Edwards; Sarah J. Lord; Yuri V. Bobryshev; David C. Whiteman; Reginald V. Lord

Collaboration


Dive into the Jesper L. V. Maag's collaboration.

Top Co-Authors

Avatar

Marcel E. Dinger

Garvan Institute of Medical Research

View shared research outputs
Top Co-Authors

Avatar

Dominik C. Kaczorowski

Garvan Institute of Medical Research

View shared research outputs
Top Co-Authors

Avatar

Angelique Levert-Mignon

University of Notre Dame Australia

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Melissa Thomas

University of Notre Dame

View shared research outputs
Top Co-Authors

Avatar

Nenad Bartonicek

Garvan Institute of Medical Research

View shared research outputs
Top Co-Authors

Avatar

Oliver M. Fisher

University of New South Wales

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Yuri V. Bobryshev

University of New South Wales

View shared research outputs
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge